Supporting equitable access to legal and regulated psychedelic medicine for all Canadians.

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada.


Click image to enlarge

MAPS Canada presented a webinar:

Emerging Regulatory Frameworks for Psychedelics in Canada: Impact on Access

December 1, 2022, 4:00 pm PST/7:00 pm EST

About this webinar:

  1. Examine and explain the current Canadian regulatory landscape as it pertains to psychedelics.
  2. Discuss the emerging changes in the regulatory landscape for psychedelic therapy in Canada.
  3. Provide insights on Indigenous sovereignty and relations between First Nations and the Nation of Canada in relation to healing practices.
  4. Discuss practitioner’s perspective of the changing regulatory landscape and its impact on ensuring safe and effective access to psychedelic medicines and treatments.


Current Canadian drug legislation prohibits legal use of most psychedelic medicines (excluding ketamine). However, there are some ways to  access legal psychedelic medicine currently, i.e., through Section 56 exemptions and the Special Access Program (SAP).

Changes in Canadian psychedelic drug policy are emerging in Alberta and other provinces. These new policies and regulations have the potential to set a precedent for the rest of Canada. 

However, concerns have been noted with these proposed changes and their impact on access. Furthermore, Indigenous perspectives have often been left out of the landscape of drug policy and research.

Join MAPS Canada as we provide exposition on the current regulatory landscape and bring together practitioners in the field of psychedelic therapy and science to discuss their experiences with access under the current regulatory framework, as well as their hopes for and concerns with future regulations pertaining to psychedelic medicines and treatments.

If you want to connect with other prescribers and practitioners who are interested in using the SAP for accessing legal psychedelic therapy for clients and patients, please consider being a part of our SAP Community of practice. For more information, CLICK HERE.

About Our Panelists

Madison Nobbs, RN headshotMadison Nobbs, RN is a Registered Nurse with 10 years of experience, specialized in health care delivery, operations and compliance including ketamine assisted therapy (KAT) and psychedelic assisted therapy via Health Canada’s Special Access Program. 

She is the manager of programming at Psy Integrated Health, a benefit corporation supporting independent health and wellness centers to develop capacity and innovate in the integrative and transformative health spaces. Madison is also the current Executive Director of the not-for-profit, the Ketamine Assisted Therapy Association (KATA) of Canada, an organization focused on accessibility to KAT. 

Madison is a mentor to other nurses who want to work in the psychedelic field and believes that nurses have a major role to play in advocating for accessibility, in creating community, in health promotion and in empowering individuals.

Francine Douglas, BA headshotFrancine Douglas, BA, is Stó:lō from Sts’ailes Nation and Tsimshian from Metlakatla Nation. Francine values and upholds her cultural teachings. Francine’s desire to support First Nation families and communities through the impacts of colonialism, assimilation and displacement has brought her to a diverse career in mental health, traditional medicine, business and cultural tourism.

Francine currently works with the Thálé:ylexw awtxw Foundation, The House of the Life Givers, a grassroots Stó:lō womxn’s group with a purpose to support the growth and empowerment of Indigenous womxn in S’ólh Téméxw, the Stó:lō traditional territory. 

Francine also works with Sacred Circle Wellness, supporting their vision for a healthcare system that honors Indigenous knowledge and ancestral traditional medicine. Francine considers her work with Sacred Circle Wellness one of the most powerful ways to support First Nations people in preserving their traditional knowledge, promoting cultural healing practices and reconnecting to their traditional territories.

Francine holds a Bachelor of Arts degree in psychology and anthropology from the University of British Columbia and was the valedictorian of the Ch’nook Indigenous Business Program from the Sauder School of Business. 

Valorie Masuda, MD headshotValorie Masuda, MD, FCFP(EM)(PC) GPO, is a palliative care physician and general practitioner in oncology working in the Cowichan Valley on Vancouver Island. She is an Associate Professor of Clinical Medicine at the University of British Columbia and is working on a clinical trial demonstrating the feasibility of delivering psilocybin therapy in a group set, setting and integration model with Roots to Thrive (RTT). She is certified in psychedelic medicine through the California Institute of Integral Studies and has also received training through Therapsil and Roots to Thrive.  

She has been working in the psychedelic space since 2020 using psilocybin-assisted therapy for palliative patients, navigating the Section 56 Exemption and later, the Special Access Program (SAP)  through the RTT psilocybin assisted program, to support patients with distress secondary to their serious cancer diagnosis. RTT has treated 24 patients in groups and 4 patients individually with psilocybin. They are currently developing a clinical trial to continue providing this service as Health Canada has told RTT that they will not allow them to apply through SAP.

Reverdi Darda, RN, is the President and CEO of Cena Life Inc., an Alberta based mental health services company and is also a new member of the MAPS Canada Board of Directors. With over 30 years of experience as a Registered Nurse and executive leader, Reverdi has wide-ranging knowledge about healthcare operations, policy and program development, strategic planning, and community engagement. She understands the challenges that healthcare systems and their structures have in offering individuals and families consistent, reliable, client focused services. She is passionate about bringing evidence-based innovation forward to those in need.

Reverdi is Metis and a direct descendant of Damase Carriere who fought against Canadian Colonialism beside Louis Riel in the heroic Metis North-West Resistance of 1885. Her passion to engage communities and work together for the equity and inclusion of all is reflective in her family’s legacy.

Reverdi has held executive and leadership roles within the public, government, and non-profit sectors. Her strategic, analytic, communication, and people skills along with her determination, good humor, and versatility have consistently been considered an integral part of her success in leadership roles. Reverdi creates safe spaces and builds trusting relationships with all levels of professionals, including within communities.

Michelle ScottMichelle (aka Shel) Scott (she/her) is an occupational therapist working in mental health in Toronto Ontario. She also leads the Toronto-based Policy and Advocacy group for MAPS Canada.

Her goal is to expand access to above-ground psychedelic medicines in a way that’s ethical, sustainable, and responsible. Her interests include mental health, cognitive science, philosophy, neuroscience, Indigenous ontologies and worldviews, meditative and contemplative practices, dialectics, and the intersection between science and spirituality.

In her free time she can be found going to concerts, dancing, playing music (alone or with friends), spending time outdoors, reading science fiction, watching hockey, and enjoying amazing food.




MAPS Canada is powered by a large and dedicated group of volunteers!

Interested in learning more about scientific research on psychedelics?

Then consider this your invitation to join the MAPS Canada virtual Journal Club.

Each Journal Club session is one hour to ninety minutes long, and features typically two speakers (15 – 20 minutes each) followed by an open Q + A.

8:00 pm ET, the second-to-last Thursday of each month

Meetings are held on Zoom

Anyone with an interest in psychedelic science and research, anywhere in the world, is welcome to attend.